Literature DB >> 27160985

A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.

David A Loewenstein1, Rosie E Curiel2, Maria T Greig3, Russell M Bauer4, Marian Rosado2, Dawn Bowers4, Meredith Wicklund4, Elizabeth Crocco2, Michael Pontecorvo5, Abhinay D Joshi5, Rosemarie Rodriguez3, Warren W Barker3, Jacqueline Hidalgo3, Ranjan Duara6.   

Abstract

OBJECTIVE: To examine the utility of a novel "cognitive stress test" to detect subtle cognitive impairments and amyloid load within the brains of neuropsychologically normal community-dwelling elders.
METHODS: Participants diagnosed as cognitively normal (CN), subjective memory impairment (SMI), mild cognitive impairment (MCI), and preclinical mild cognitive impairment (PreMCI) were administered the Loewenstein-Acevedo Scale for Semantic Interference and Learning (LASSI-L), a sensitive test of proactive semantic interference (PSI), retroactive semantic interference, and, uniquely, the ability to recover from the effects of PSI. Ninety-three subjects (31 men and 62 women) were recruited from three academic institutions in a research consortium. A subset of these individuals underwent 18F florbetapir positron emission tomography scanning. Relative percentages of impairment for each diagnostic group on the LASSI-L were calculated by χ(2) and Fisher's exact tests. Spearman's rho was used to examine associations between amyloid load and different cognitive measures.
RESULTS: LASSI-L deficits were identified among 89% of those with MCI, 47% with PreMCI, 33% with SMI, and 13% classified as CN. CN subjects had no difficulties with recovery from PSI, whereas SMI, preMCI, and MCI participants evidenced deficits in recovery from PSI effects. Among a subgroup of participants with normal scores on traditional neuropsychological tests, the strong associations were between the failure to recover from the effects of PSI and amyloid load in the brain.
CONCLUSION: Failure to recover or compensate for the effects of PSI on the LASSI-L distinguishes the LASSI-L from other widely used neuropsychological tests and appears to be sensitive to subtle cognitive impairments and increasing amyloid load.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LASSI-L; MCI; PreMCI; amyloid; proactive interference recovery

Mesh:

Substances:

Year:  2016        PMID: 27160985      PMCID: PMC5026876          DOI: 10.1016/j.jagp.2016.02.056

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  22 in total

1.  Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.

Authors:  Reisa A Sperling; Keith A Johnson; P Murali Doraiswamy; Eric M Reiman; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Alan Carpenter; Mat D Davis; Ming Lu; Matthew Flitter; Abhinay D Joshi; Christopher M Clark; Michael Grundman; Mark A Mintun; Daniel M Skovronsky; Michael J Pontecorvo
Journal:  Neurobiol Aging       Date:  2012-08-09       Impact factor: 4.673

2.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Authors:  Willemijn J Jansen; Rik Ossenkoppele; Dirk L Knol; Betty M Tijms; Philip Scheltens; Frans R J Verhey; Pieter Jelle Visser; Pauline Aalten; Dag Aarsland; Daniel Alcolea; Myriam Alexander; Ina S Almdahl; Steven E Arnold; Inês Baldeiras; Henryk Barthel; Bart N M van Berckel; Kristen Bibeau; Kaj Blennow; David J Brooks; Mark A van Buchem; Vincent Camus; Enrica Cavedo; Kewei Chen; Gael Chetelat; Ann D Cohen; Alexander Drzezga; Sebastiaan Engelborghs; Anne M Fagan; Tormod Fladby; Adam S Fleisher; Wiesje M van der Flier; Lisa Ford; Stefan Förster; Juan Fortea; Nadia Foskett; Kristian S Frederiksen; Yvonne Freund-Levi; Giovanni B Frisoni; Lutz Froelich; Tomasz Gabryelewicz; Kiran Dip Gill; Olymbia Gkatzima; Estrella Gómez-Tortosa; Mark Forrest Gordon; Timo Grimmer; Harald Hampel; Lucrezia Hausner; Sabine Hellwig; Sanna-Kaisa Herukka; Helmut Hildebrandt; Lianna Ishihara; Adrian Ivanoiu; William J Jagust; Peter Johannsen; Ramesh Kandimalla; Elisabeth Kapaki; Aleksandra Klimkowicz-Mrowiec; William E Klunk; Sebastian Köhler; Norman Koglin; Johannes Kornhuber; Milica G Kramberger; Koen Van Laere; Susan M Landau; Dong Young Lee; Mony de Leon; Viviana Lisetti; Alberto Lleó; Karine Madsen; Wolfgang Maier; Jan Marcusson; Niklas Mattsson; Alexandre de Mendonça; Olga Meulenbroek; Philipp T Meyer; Mark A Mintun; Vincent Mok; José Luis Molinuevo; Hanne M Møllergård; John C Morris; Barbara Mroczko; Stefan Van der Mussele; Duk L Na; Andrew Newberg; Agneta Nordberg; Arto Nordlund; Gerald P Novak; George P Paraskevas; Lucilla Parnetti; Gayan Perera; Oliver Peters; Julius Popp; Sudesh Prabhakar; Gil D Rabinovici; Inez H G B Ramakers; Lorena Rami; Catarina Resende de Oliveira; Juha O Rinne; Karen M Rodrigue; Eloy Rodríguez-Rodríguez; Catherine M Roe; Uros Rot; Christopher C Rowe; Eckart Rüther; Osama Sabri; Páscual Sanchez-Juan; Isabel Santana; Marie Sarazin; Johannes Schröder; Christin Schütte; Sang W Seo; Femke Soetewey; Hilkka Soininen; Luiza Spiru; Hanne Struyfs; Charlotte E Teunissen; Magda Tsolaki; Rik Vandenberghe; Marcel M Verbeek; Victor L Villemagne; Stephanie J B Vos; Linda J C van Waalwijk van Doorn; Gunhild Waldemar; Anders Wallin; Åsa K Wallin; Jens Wiltfang; David A Wolk; Marzena Zboch; Henrik Zetterberg
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

3.  Stability of neurocognitive impairment in different subtypes of mild cognitive impairment.

Authors:  David A Loewenstein; Amarilis Acevedo; Joscelyn Agron; Ranjan Duara
Journal:  Dement Geriatr Cogn Disord       Date:  2006-11-22       Impact factor: 2.959

4.  Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions.

Authors:  Larry G Brooks; David A Loewenstein
Journal:  Alzheimers Res Ther       Date:  2010-09-29       Impact factor: 6.982

5.  An evaluation of deficits in semantic cueing and proactive and retroactive interference as early features of Alzheimer's disease.

Authors:  Elizabeth Crocco; Rosie E Curiel; Amarilis Acevedo; Sara J Czaja; David A Loewenstein
Journal:  Am J Geriatr Psychiatry       Date:  2013-06-12       Impact factor: 4.105

6.  Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden.

Authors:  Miranka Wirth; Sylvia Villeneuve; Renaud La Joie; Shawn M Marks; William J Jagust
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

7.  Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease.

Authors:  Ranjan Duara; David A Loewenstein; Qian Shen; Warren Barker; Elizabeth Potter; Daniel Varon; Kristen Heurlin; Rik Vandenberghe; Christopher Buckley
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

8.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.

Authors:  Sylvia Villeneuve; Gil D Rabinovici; Brendan I Cohn-Sheehy; Cindee Madison; Nagehan Ayakta; Pia M Ghosh; Renaud La Joie; Samia Kate Arthur-Bentil; Jacob W Vogel; Shawn M Marks; Manja Lehmann; Howard J Rosen; Bruce Reed; John Olichney; Adam L Boxer; Bruce L Miller; Ewa Borys; Lee-Way Jin; Eric J Huang; Lea T Grinberg; Charles DeCarli; William W Seeley; William Jagust
Journal:  Brain       Date:  2015-05-06       Impact factor: 13.501

9.  Cognition, reserve, and amyloid deposition in normal aging.

Authors:  Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

Review 10.  Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review.

Authors:  Dorene M Rentz; Mario A Parra Rodriguez; Rebecca Amariglio; Yaakov Stern; Reisa Sperling; Steven Ferris
Journal:  Alzheimers Res Ther       Date:  2013-11-21       Impact factor: 6.982

View more
  28 in total

1.  Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.

Authors:  David A Loewenstein; Rosie E Curiel; Clinton Wright; Xiaoyan Sun; Noam Alperin; Elzabeth Crocco; Sara J Czaja; Arlene Raffo; Ailyn Penate; Jose Melo; Kimberly Capp; Monica Gamez; Ranjan Duara
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.

Authors:  David A Loewenstein; Rosie E Curiel; Steven DeKosky; Monica Rosselli; Russell Bauer; Maria Grieg-Custo; Ailyn Penate; Chunfei Li; Gabriel Lizagarra; Todd Golde; Malek Adjouadi; Ranjan Duara
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Visual Object Discrimination Impairment as an Early Predictor of Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Leslie S Gaynor; Rosie E Curiel Cid; Ailyn Penate; Mónica Rosselli; Sara N Burke; Meredith Wicklund; David A Loewenstein; Russell M Bauer
Journal:  J Int Neuropsychol Soc       Date:  2019-08       Impact factor: 2.892

4.  Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia.

Authors:  Shanna L Burke; Miriam J Rodriguez; Warren Barker; Maria T Greig-Custo; Monica Rosselli; David A Loewenstein; Ranjan Duara
Journal:  J Int Neuropsychol Soc       Date:  2017-09-18       Impact factor: 2.892

5.  A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease.

Authors:  Elizabeth A Crocco; David A Loewenstein; Rosie E Curiel; Noam Alperin; Sara J Czaja; Philip D Harvey; Xiaoyan Sun; Joshua Lenchus; Arlene Raffo; Ailyn Peñate; Jose Melo; Lee Sang; Rosemery Valdivia; Karen Cardenas
Journal:  J Psychiatr Res       Date:  2017-08-24       Impact factor: 4.791

6.  Dementia-Related Neuropsychological Testing Considerations in Non-Hispanic White and Latino/Hispanic Populations.

Authors:  Shanna L Burke; Mitra Naseh; Miriam J Rodriguez; Aaron Burgess; David Loewenstein
Journal:  Psychol Neurosci       Date:  2019-03-11

7.  Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.

Authors:  David A Loewenstein; Rosie E Curiel; Steven DeKosky; Russell M Bauer; Monica Rosselli; Salvador M Guinjoan; Malek Adjouadi; Ailyn Peñate; William W Barker; Sindy Goenaga; Todd Golde; Maria T Greig-Custo; Kevin S Hanson; Chunfei Li; Gabriel Lizarraga; Michael Marsiske; Ranjan Duara
Journal:  Neurology       Date:  2018-08-03       Impact factor: 9.910

8.  Does a cognitive stress test predict progression from mild cognitive impairment to dementia equally well in clinical versus population-based settings?

Authors:  Joanne C Beer; Beth E Snitz; Chung-Chou H Chang; David A Loewenstein; Mary Ganguli
Journal:  Int Psychogeriatr       Date:  2018-01-16       Impact factor: 3.878

9.  Effects of Bilingualism on Verbal and Nonverbal Memory Measures in Mild Cognitive Impairment.

Authors:  Mónica Rosselli; David A Loewenstein; Rosie E Curiel; Ailyn Penate; Valeria L Torres; Merike Lang; Maria T Greig; William W Barker; Ranjan Duara
Journal:  J Int Neuropsychol Soc       Date:  2018-10-18       Impact factor: 2.892

10.  Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer.

Authors:  Ashley Henneghan; Vikram Rao; Rebecca A Harrison; Meghan Karuturi; Douglas W Blayney; Oxana Palesh; Shelli R Kesler
Journal:  Neurotox Res       Date:  2020-01-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.